Loading clinical trials...
Loading clinical trials...
An Open-labeled, Multi-center, Randomized, Prospective Phase III Study Comparing CMAB304 in Combination With CHOP to CHOP Alone With CMAB304 Maintenance in Patients With DLBCL
Conditions
Interventions
CHOP combined with CMAB304
CHOP, CMAB304
Locations
1
China
SUN-YAT-SEN university cancer center
Guangzhou, Guangdong, China
Start Date
September 1, 2006
Primary Completion Date
December 1, 2010
Completion Date
February 1, 2011
Last Updated
October 26, 2011
NCT05006716
NCT06026319
NCT07368270
NCT07255963
NCT05940272
NCT06352242
Lead Sponsor
Shanghai CP Guojian Pharmaceutical Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions